Cargando…

A Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence

We describe a new form of inherited immunodeficiency revealed by an N-ethyl-N-nitrosourea (ENU)-induced mutation called elektra. Homozygotes showed enhanced susceptibility to bacterial and viral infections, and diminished numbers of T cells and inflammatory monocytes that failed to proliferate upon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Michael, Krebs, Philippe, Crozat, Karine, Li, Xiaohong, Croker, Ben A., Siggs, Owen M., Popkin, Daniel, Du, Xin, Lawson, Brian R., Theofilopoulos, Argyrios N., Xia, Yu, Khovananth, Kevin, Moresco, Eva Marie Y., Satoh, Takashi, Takeuchi, Osamu, Akira, Shizuo, Beutler, Bruce
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861894/ https://www.ncbi.nlm.nih.gov/pubmed/20190759 http://dx.doi.org/10.1038/ni.1847

Ejemplares similares

Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL
por: Goldshtein, Aviya, et al.
Publicado: (2016)

Commitment to the Regulatory T Cell Lineage Requires CARMA1 in the Thymus but Not in the Periphery
por: Barnes, Michael J, et al.
Publicado: (2009)

ZBTB1 is a determinant of lymphoid development
por: Siggs, Owen M., et al.
Publicado: (2012)

Mechanistic understanding of human SLFN11
por: Metzner, Felix J., et al.
Publicado: (2022)

Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response
por: Alvi, Erin, et al.
Publicado: (2023)

Hypopigmentation and Maternal-Zygotic Embryonic Lethality Caused by a Hypomorphic Mbtps1 Mutation in Mice
por: Rutschmann, Sophie, et al.
Publicado: (2012)

Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase
por: Garvie, Colin W., et al.
Publicado: (2021)

SLFN14 gene mutations associated with bleeding
por: Stapley, Rachel J., et al.
Publicado: (2019)

SLFN11’s surveillance role in protein homeostasis
por: Murai, Yasuhisa, et al.
Publicado: (2022)

ENU-induced phenovariance in mice: inferences from 587 mutations
por: Arnold, Carrie N, et al.
Publicado: (2012)

Ribosome dysfunction underlies SLFN14-related thrombocytopenia
por: Ver Donck, Fabienne, et al.
Publicado: (2023)

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
por: Theofilopoulos, Argyrios N, et al.
Publicado: (2001)

SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
por: Xu, Qiao Ping, et al.
Publicado: (2023)

The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid–sensing TLRs and ligands to endolysosomes
por: Rimann, Ivo, et al.
Publicado: (2022)

Essential cell-extrinsic requirement for PDIA6 in lymphoid and myeloid development
por: Choi, Jin Huk, et al.
Publicado: (2020)

Characterization of Novel Ribosome-Associated Endoribonuclease SLFN14 from Rabbit Reticulocytes
por: Pisareva, Vera P., et al.
Publicado: (2015)

Clinico-pathological and transcriptomic determinants of SLFN11 expression in invasive breast carcinoma
por: Zoppoli, Gabriele, et al.
Publicado: (2015)

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
por: Murai, Junko, et al.
Publicado: (2016)

SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
por: Nakata, Satoshi, et al.
Publicado: (2022)

Modulation of SLFN11 induces changes in DNA Damage response in breast cancer
por: Raynaud, Christophe Michel, et al.
Publicado: (2023)

Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity
por: Lawson, Brian R., et al.
Publicado: (2004)

Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation
por: Fletcher, Sarah J., et al.
Publicado: (2018)

Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
por: Polokhov, Dmitrii, et al.
Publicado: (2023)

PB1791: SLFN11 REGULATES MULTIPLE PATHWAYS THAT ARE IMPORTANT FOR TREATMENT RESPONSE IN AML
por: Small, Sara, et al.
Publicado: (2023)

BINDING OF SOLUBLE IMMUNE COMPLEXES TO HUMAN LYMPHOBLASTOID CELLS : I. Characterization of Receptors for IgG Fc and Complement and Description of the Binding Mechanism
por: Theofilopoulos, Argyrios N., et al.
Publicado: (1974)

RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLS : PROPERTIES AND BIOLOGICAL SIGNIFICANCE
por: Theofilopoulos, Argyrios N., et al.
Publicado: (1974)

Insulin–InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages
por: Xia, Pengyan, et al.
Publicado: (2015)

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
por: Ballestrero, Alberto, et al.
Publicado: (2017)

SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
por: Mezzadra, Riccardo, et al.
Publicado: (2019)

The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response
por: Coleman, Niamh, et al.
Publicado: (2020)

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models
por: Winkler, Claudia, et al.
Publicado: (2020)

Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development
por: Moribe, Fumiya, et al.
Publicado: (2021)

SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
por: Fischietti, Mariafausta, et al.
Publicado: (2022)

DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
por: Thompson, Benjamin J., et al.
Publicado: (2015)

Nitrogen-dependent coordination of cell cycle, quiescence and TAG accumulation in Chlamydomonas
por: Takeuchi, Tomomi, et al.
Publicado: (2019)

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy
por: Kagami, Takuma, et al.
Publicado: (2020)

Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin
por: Peng, Yaojun, et al.
Publicado: (2019)

Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma
por: Liu, Yifu, et al.
Publicado: (2021)

Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
por: Willis, Sophie E., et al.
Publicado: (2021)

Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption
por: Vit, Gianmatteo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qccir30c3bshegpv3g55g2kamg